Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer
- Citation:
- JAMA Oncol vol 9 (3) :404-13
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3687
- Children:
- None
- Pharmas:
- Pfizer
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180794, UG1CA233163, UG1CA233253, UG1CA233290, UG1CA233320, UG1CA233337, UG1CA233339, UG1CA189954, U10CA180863 CCTG; UG1CA233196, U10CA180820 ECOG-ACRIN; U10CA180868 NRG; U10CA180888, U10CA180819, UG1CA233163 SWOG, R01CA169141
- Corr. Author:
- Authors:
- En Cheng Qian Shi Anthony F. Shields Andrew B. Nixon Ardaman P. Shergill Chao Ma Katherine A. Guthrie Felix Couture Philip Kuebler Pankaj Kumar Benjamin Tan Smitha S. Krishnamurthi Kimmie Ng Eileen M. O'Reilly Justin C. Brown Philip A. Philip Bette J. Caan Elizabeth M. Cespedes Feliciano Jeffrey A. Meyerhardt
- Networks:
- HEARTLAND, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC010, LAPS-NY016, OH027
- Study
- Alliance-A151939
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- N/A, 3
- Keywords: